Neonatal hyperpigmentation: Diagnosis of familial glucocorticoid deficiency with a novel mutation in the melanocortin-2 receptor gene

1Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Familial glucocorticoid deficiency (FGD), a rare autosomal recessive disorder of insensitivity to adrenocorticotropic hormone (ACTH), is characterized by isolated glucocorticoid deficiency and preserved mineralocorticoid production. The clinical features include generalized hyperpigmentation, hypoglycemia, failure to thrive, and recurrent infections. Here we describe the case of an infant who exhibited generalized hyperpigmentation and hypoglycemia. A high morning blood ACTH level and low blood cortisol level confirmed the diagnosis of FGD. The patient was found to be homozygous for a novel mutation in the melanocortin-2 receptor gene (635insC, I154H). Early initiation of corticosteroid treatment led to normalization of morning blood ACTH levels and the patient thrived, with subsequent fading of the hyperpigmentation. © 2013 Wiley Periodicals, Inc.

Cite

CITATION STYLE

APA

Jacoby, E., Barzilai, A., Laufer, J., Pade, S., Anikster, Y., Pinhas-Hamiel, O., & Greenberger, S. (2014). Neonatal hyperpigmentation: Diagnosis of familial glucocorticoid deficiency with a novel mutation in the melanocortin-2 receptor gene. Pediatric Dermatology, 31(1). https://doi.org/10.1111/pde.12247

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free